NCT01927562View on ClinicalTrials.gov

Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 13, 2013

Primary Completion Date

April 7, 2017

Study Completion Date

March 16, 2018

Conditions
Type II Diabetes
Interventions
DEVICE

Fractyl Duodenal Remodeling System

Trial Locations (1)

Unknown

INDISA, Santiago

Sponsors
All Listed Sponsors
lead

Fractyl Health Inc.

INDUSTRY

NCT01927562 - Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes | Biotech Hunter | Biotech Hunter